Cargando…
Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?
Mantle cell lymphoma has been recognized as a distinct entity from the other non-Hodgkin lymphomas in middle 1990's. It carries a worst prognosis among all mature B-cell malignancies. Cyclin D1 and recently SOX11 are the hallmarks for this disease. Even if it is highly responsive to induction t...
Autores principales: | Petković, Ivan, Pejčić, Ivica, Vrbić, Svetislav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355653/ https://www.ncbi.nlm.nih.gov/pubmed/25784834 http://dx.doi.org/10.5114/wo.2014.45111 |
Ejemplares similares
-
Transformation of primary cutaneous follicle centre lymphoma into primary cutaneous diffuse large B-cell lymphoma of other type
por: Petković, Ivan Z., et al.
Publicado: (2017) -
Renal Infiltration of Follicular Lymphoma
por: Petković, Ivan, et al.
Publicado: (2014) -
Two-Year Complete Remission of Diffuse Large B-Cell Lymphoma in an Immunological Nonresponder HIV-Infected Patient: Case Report
por: Vrbic, Miodrag, et al.
Publicado: (2017) -
Resolving the Phoma enigma
por: Chen, Q., et al.
Publicado: (2015) -
Mantle cell lymphoma management trends and novel agents: where are we
going?
por: Pu, Jeffrey J., et al.
Publicado: (2022)